Comparative effectiveness of risankizumab vs. ustekinumab in bio-naïve Crohn's disease patients: A real-world multicentre retrospective cohort study

被引：0
|
作者：
Aldiabat, M. [1 ]
Yarur, A. [2 ]
Peyrin-Biroulet, L. [3 ]
Loftus-Jr, E., V [4 ,5 ]
Colombel, J. F.
Deepak, P. [6 ]
机构：
[1] Washington Univ St Louis, Sch Med, Gastroenterol, St Louis, MO USA
[2] Cedars Sinai Med Ctr, Gastroenterol, Los Angeles, CA USA
[3] Nancy Univ Hosp, Inflammatory Bowel Dis IBD Unit, Vandoeuvre Les Nancy, France
[4] Mayo Clin, Coll Med, Gastroenterol, Rochester, MN USA
[5] Icahn Sch Med Mt Sinai, Gastroenterol, New York, NY USA
[6] Washington Univ, Sch Med St Louis, Gastroenterol, St Louis, MO USA
来源：
JOURNAL OF CROHNS & COLITIS | 2025年 / 19卷
关键词：
D O I：
10.1093/ecco-jcc/jjae190.0141
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
DOP102
引用
收藏
页码：i268 / i269
页数：2
相关论文
共 50 条
  • [21] REAL-WORLD EFFECTIVENESS AND SAFETY OF USTEKINUMAB FOR THE TREATMENT OF CROHN'S: THE SCOTTISH USTEKINUMAB COHORT
    Plevris, Nikolas
    Robertson, Andrew
    Fulforth, James
    Hall, Rebecca
    Jenkinson, Philip
    Campbell, Iona
    Kane, Claire
    Arnott, Ian
    Sutherland, Diarmid
    Veryan, Jennifer
    Saunders, Jennifer
    Lam, Wai
    Naismith, Graham
    Chuah, Cher
    Kelly, Christopher
    Watts, David
    Gaya, Daniel
    Macdonald, Jonathan
    Sennan, John-Paul
    Jafferbhoy, Hasnain
    Mowat, Craig
    Bain, Gillian
    Jones, Gareth
    Lees, Charlie
    GUT, 2021, 70 : A112 - A113
  • [22] Real-world Effectiveness and Safety of Risankizumab in Patients with Moderate to Severe Multirefractory Crohn's Disease: A Belgian Multicentric Cohort Study
    Alsoud, Dahham
    Sabino, Joao
    Franchimont, Denis
    Cremer, Anneline
    Busschaert, Julie
    D'Heygere, Francois
    Bossuyt, Peter
    Vijverman, Anne
    Vermeire, Severine
    Ferrante, Marc
    INFLAMMATORY BOWEL DISEASES, 2024, 30 (12) : 2289 - 2296
  • [23] Real-World Effectiveness of Ustekinumab Dose Intensification in Crohn's Disease
    Srinivasan, Ashish
    van Langenberg, Daniel
    De Cruz, Peter
    INFLAMMATORY BOWEL DISEASES, 2021, 27 (06) : E69 - E69
  • [24] Effectiveness of Vedolizumab in Bio-Naïve Chinese Patients with Crohn's Disease: A Subgroup Analysis of Second Interim Analysis of the VALUE Study
    Guo, H.
    Shen, H.
    Jiang, Q.
    Xu, X.
    Qian, X.
    Zhou, F.
    Chen, M.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1806 - i1807
  • [25] Real-world effectiveness and safety of ustekinumab and vedolizumab in elderly patients with Crohn’s disease
    Rajat Garg
    Manik Aggarwal
    Abdul Mohammed
    Jean Paul Achkar
    Bret Lashner
    Jessica Philpott
    Benjamin Cohen
    Taha Qazi
    Florian Rieder
    Miguel Regueiro
    Benjamin Click
    Indian Journal of Gastroenterology, 2023, 42 : 718 - 723
  • [26] Real-world effectiveness and safety of ustekinumab and vedolizumab in elderly patients with Crohn's disease
    Garg, Rajat
    Aggarwal, Manik
    Mohammed, Abdul
    Achkar, Jean Paul
    Lashner, Bret
    Philpott, Jessica
    Cohen, Benjamin
    Qazi, Taha
    Rieder, Florian
    Regueiro, Miguel
    Click, Benjamin
    INDIAN JOURNAL OF GASTROENTEROLOGY, 2023, 42 (05) : 718 - 723
  • [27] Long-Term Effectiveness and Safety of Ustekinumab for The Treatment of Crohn′s Disease: A Brazilian Multicentre Real-world Study
    Oleg, Knyazev
    Albina, Lishchinskaya
    Anatoliy, Konoplyannikov
    Anna, Kagramanova
    Nina, Fadeeva
    Dmitriy, Kulakov
    Anait, Babayan
    Mariya, Zvyaglova
    Asfold, Parfenov
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S2 - S2
  • [28] REAL-WORLD EFFECTIVENESS AND SAFETY OF USTEKINUMAB AND VEDOLIZUMAB IN ELDERLY PATIENTS WITH CROHN'S DISEASE
    Garg, Rajat
    Aggarwal, Manik
    Mohammed, Abdul
    Achkar, Jean-Paul
    Lashner, Bret
    Philpott, Jessica
    Cohen, Benjamin L.
    Rieder, Florian
    Qazi, Taha
    Regueiro, Miguel D.
    Click, Benjamin H.
    GASTROENTEROLOGY, 2021, 160 (06) : S560 - S560
  • [29] REAL WORLD EFFICACY OF RISANKIZUMAB IN CROHN'S DISEASE PATIENTS WITH PRIOR EXPOSURE TO USTEKINUMAB
    Chugh, Rishika
    Kattah, Michael
    Mahadevan, Uma
    GASTROENTEROLOGY, 2024, 166 (05) : S1151 - S1151
  • [30] Vedolizumab vs. ustekinumab for Crohn's disease: comparative effectiveness in a real-life observational cohort study (ICC case series)
    Biemans, V.
    van der Woude, C.
    van der Meulen-de Jong, A.
    Dijkstra, G.
    de Boer, N.
    Oldenburg, B.
    Ponsioen, C.
    de Vries, A.
    Wintjens, D.
    Hoentjen, F.
    Pierik, M.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S66 - S67
12345